Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Published on December 23, 2024

Under the terms of their expanded agreement, both companies will co-fund research and development costs . Sanofi will pay EUR 50M upfront to

Continue reading on website
Other news

El Salvador secures IMF deal as Bitcoin acceptance turns voluntary

December 23, 2024
El Salvador has secured a $1.4 billion agreement with the International Monetary Fund, marking a shift in the country’s crypto policies by

After decades in office, Casey couldn’t overcome voters' desire for change

December 23, 2024
that, unfortunately, was the American Rescue Plan,” which provided funding for local governments and support for hard-pressed families, who